CompletedNCT00194116
Divalproex extended release compared with placebo for bipolar I or II depression
About this title
Read the official source — NCT00194116Medication studyAges 16–65United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 16 years to 65 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateSeptember 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 54
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 16 Years to 65 Years
- Official registry ID
- NCT00194116
- Official title
Show the full official title
Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Divalproex Sodium ER and Placebo.
Who was this study for?
Listed age limits: 16 years to 65 years.
